Harlow, United Kingdom

Bohdan Waszkowycz

This inventor holds 5 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Chiesi Farmaceutici S.p.a., Genentech, Inc., F. Hoffmann-La Roche Ag. Active years: 2013-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bohdan Waszkowycz. Retrieved from https://idiyas.com/inventor/bohdan-waszkowycz-eansa4ku

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 20.0

 

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 41(Granted Patents)


Location History:

  • Slough, GB (2013)
  • Macclesfield, GB (2013)
  • Harlow, GB (2013 - 2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Bohdan Waszkowycz: Innovator in Pharmaceutical Compounds

Introduction

Bohdan Waszkowycz, based in Harlow, GB, is a notable inventor with an impressive portfolio of five patents to his name. His work primarily focuses on the development of novel pharmaceutical compounds that target specific disorders mediated by lipid kinases.

Latest Patents

Among his recent innovations, one of the key patents is for Benzoxazepin compounds selective for PI3K P110 delta and methods of use. This invention includes Benzoxazepin Formula I compounds, which encompass a range of stereoisomers, geometric isomers, tautomers, metabolites, and pharmaceutically acceptable salts. These compounds are designed to inhibit the delta isoform of PI3K, providing therapeutic options for treating disorders such as inflammation, immunological disorders, and cancer. The patent elaborates on methodologies for using these compounds in various diagnostic and therapeutic contexts in mammalian cells.

Another significant patent filed by Waszkowycz pertains to heterocyclic compounds and their methods of use. Similar to the previous patent, this innovation revolves around Formula I compounds that inhibit the delta isoform of PI3K, outlining their potential in the diagnosis, prevention, and treatment of related disorders.

Career Highlights

Throughout his career, Bohdan Waszkowycz has contributed to the field of pharmaceuticals by working with esteemed organizations such as Genentech, Inc. and Chiesi Farmaceutici S.p.a. His expertise in drug development and innovative thinking has positioned him as a key player in the exploration of cancer and immunological treatments.

Collaborations

Waszkowycz has collaborated with prominent colleagues in his field, including Robert Andrew Heald and Brian Salvatore Safina. These partnerships have further enriched his research endeavors and expanded the potential applications of his inventions.

Conclusion

Bohdan Waszkowycz's contributions to the realm of pharmaceutical innovations through his patents highlight his significant role as an inventor. His work not only aims to advance medical science but also seeks to provide hope for patients suffering from complex disorders. As he continues to explore and innovate, the impact of his inventions may lead to transformative treatments for numerous health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…